Farnesol inhibits in vitro growth of the Cryptococcus neoformans species complex with no significant changes in virulence-related exoenzymes (Q84117070)

From Wikidata

Jump to navigation Jump to search

scientific article published on 19 April 2012

Language	Label	Description	Also known as
English	Farnesol inhibits in vitro growth of the Cryptococcus neoformans species complex with no significant changes in virulence-related exoenzymes	scientific article published on 19 April 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580194%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Farnesol inhibits in vitro growth of the Cryptococcus neoformans species complex with no significant changes in virulence-related exoenzymes (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580194%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Cryptococcus neoformans

1 reference

based on heuristic

inferred from title

Débora de Souza Collares Maia Castelo-Branco

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580194%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

Rossana de Aguiar Cordeiro

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580194%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

George Cândido Nogueira

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580194%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Raimunda Sâmia Nogueira Brilhante

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580194%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Carlos Eduardo Cordeiro Teixeira

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580194%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Charles Ielpo Mourão

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580194%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Manoel de Araújo Neto Paiva

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580194%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Joyce Fonteles Ribeiro

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580194%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

André Jalles Monteiro

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580194%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

José Júlio Costa Sidrim

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580194%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Marcos Fábio Gadelha Rocha

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580194%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

publication date

19 April 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580194%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Veterinary Microbiology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580194%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

159

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580194%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

3-4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580194%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

375-380

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580194%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Cryptococcus neoformans Site-2 protease is required for virulence and survival in the presence of azole drugs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Yeasts from Macrobrachium amazonicum: a focus on antifungal susceptibility and virulence factors of Candida spp

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Sesquiterpene farnesol contributes to increased susceptibility to β-lactams in strains of Burkholderia pseudomallei.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Tipranavir exhibits different effects on opportunistic pathogenic fungi.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

SEC14 is a specific requirement for secretion of phospholipase B1 and pathogenicity of Cryptococcus neoformans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

In vitro susceptibility of the yeast pathogen cryptococcus to fluconazole and other azoles varies with molecular genotype

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

PCR-REA as an important tool for the identification of Cryptococcus neoformans and Cryptococcus gattii from human and veterinary sources.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Urban pigeons (Columba livia) as a potential source of pathogenic yeasts: a focus on antifungal susceptibility of Cryptococcus strains in Northeast Brazil

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Antimicrobial effect of farnesol, a Candida albicans quorum sensing molecule, on Paracoccidioides brasiliensis growth and morphogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

In vitro antifungal susceptibilities and amplified fragment length polymorphism genotyping of a worldwide collection of 350 clinical, veterinary, and environmental Cryptococcus gattii isolates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Protective effects of farnesol against oral candidiasis in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Enhanced production of farnesol by Candida albicans treated with four azoles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Correlation of genotype and in vitro susceptibilities of Cryptococcus gattii strains from the Pacific Northwest of the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Effect of farnesol on Candida dubliniensis biofilm formation and fluconazole resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Farnesol, a potential efflux pump inhibitor in Mycobacterium smegmatis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Expanding fungal pathogenesis: Cryptococcus breaks out of the opportunistic box.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Do major species concepts support one, two or more species within Cryptococcus neoformans?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Activity and toxicity of farnesol towards Candida albicans are dependent on growth conditions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Cryptococcosis: update and emergence of Cryptococcus gattii

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

The biology of the Cryptococcus neoformans species complex

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Farnesol induces apoptosis and oxidative stress in the fungal pathogen Penicillium expansum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Virulence in Cryptococcus species

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Molecular typing of IberoAmerican Cryptococcus neoformans isolates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Enhanced pathogenicity of Candida albicans pre-treated with subinhibitory concentrations of fluconazole in a mouse model of disseminated candidiasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Farnesol decreases biofilms of Staphylococcus epidermidis and exhibits synergy with nafcillin and vancomycin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Transcriptional response of Candida parapsilosis following exposure to farnesol

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

The quorum-sensing molecule farnesol is a modulator of drug efflux mediated by ABC multidrug transporters and synergizes with drugs in Candida albicans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Inhibition of Fusarium graminearum growth and development by farnesol

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Farnesol-induced apoptosis in Candida albicans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Candida species isolated from the gastrointestinal tract of cockatiels (Nymphicus hollandicus): In vitro antifungal susceptibility profile and phospholipase activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

In vitro antifungal susceptibility of Cryptococcus gattii

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Correlation of antifungal susceptibility and molecular type within the Cryptococcus neoformans/C. gattii species complex.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

The quorum-sensing molecule E,E-farnesol--its variable secretion and its impact on the growth and metabolism of Candida species

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Identifiers

10.1016/J.VETMIC.2012.04.008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580194%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580194%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84117070&oldid=2117992732"